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The liver plays an important role in metabolism and elimination of xenobiotics, including drugs.
Determination of concentrations of proteins involved in uptake, distribution, metabolism, and excretion
of xenobiotics is required to understand and predict elimination mechanisms in this tissue. In this work,
we have fractionated homogenates of snap-frozen human liver by differential centrifugation and per-
formed quantitative mass spectrometry-based proteomic analysis of each fraction. Concentrations of
proteins were calculated by the “total protein approach”. A total of 4586 proteins were identiﬁed by at
least ﬁve peptides and were quantiﬁed in all fractions. We found that the xenobiotics transporters of the
canalicular and basolateral membranes were differentially enriched in the subcellular fractions and that
phase I and II metabolizing enzymes, the cytochrome P450s and the UDPeglucuronyl transferases, have
complex subcellular distributions. These ﬁndings show that there is no simple way to scale the data from
measurements in arbitrarily selected membrane fractions using a single scaling factor for all the proteins
of interest. This study also provides the ﬁrst absolute quantitative subcellular catalog of human liver
proteins obtained from frozen tissue specimens. Our data provide quantitative insights into the sub-
cellular distribution of proteins and can be used as a guide for development of fractionation procedures.
© 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Determination of titers of proteins involved in hepatobiliary
elimination and metabolism of drugs and other xenobiotics pro-
vides essential information for drug discovery and development.
Usually, targeted mass spectrometry (MS) analyses using stable
isotope-labeled standards by so-called “targeted proteomics” are
used for this purpose. Because targeted mass spectrometry has
limitations in sensitivity, concentrations of membrane transporters
and drug metabolizing enzymes are generally measured in sub-
cellular fractions such as microsomal pellets and enriched plasma
membranes obtained by differential centrifugation or using
commercially available kits [1e4]. However, subcellulartotal protein approach; SDS,
s for sample digestioneﬁlter-
uorescence assay; LC, liquid
; ER, endoplasmic reticulum;
tion; SLC, solute carrier; ABC,
DPeglucuronosyltransferase.
isniewski).
r Inc. This is an open access articlefractionation is often accompanied by substantial losses of sub-
cellular components, and therefore scaling of protein abundance
from subcellular fractions to whole cell or organ abundances has
been used [5]. The accuracy of the scaling leans on the assumption
that all proteins in the membrane fraction are equally scalable, that
is, that a single scaling factor can be used for all of the proteins of
interest. Surprisingly, direct evidence of the accuracy of such
scaling approaches is missing.
The “total protein approach” (TPA) is an alternative to targeted
proteomics [6,7]. This computational approach uses standard and
label-free mass spectrometry-based data and is applicable to any
biological sample [6]. The method allows proﬁling of protein
abundances expressed in concentrations across tissues and organs
[8,9]. Recently, we applied this technology to measure levels of
proteins primarily involved in xenobiotics metabolism in human
liver, puriﬁed hepatocytes, and their membrane preparations
[10,11].
In this work, we carried out subcellular fractionation of snap-
frozen human liver tissues and applied the label-free technology
to measure protein concentrations. Absolute protein content ofunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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content (determined with our recently introduced protein assay
[12]) with the TPA-based protein concentrations. This allowed us to
assess the yields for each quantiﬁed protein in the homogenate and
the subcellular fractions, respectively. We found excellent balance
between concentrations in the homogenate and the subcellular
fractions combined, indicating good accuracy of the analytical and
computational approaches used. Analysis of the quantitative dis-
tribution of subcellular marker proteins as well as drug trans-
porters and drug metabolizing enzymes revealed that both plasma
membranes and endoplasmic reticulum are heterogeneous to an
extent that compromises proper scaling. Based on this observation,
we conclude that accurate scaling of protein concentrations
measured in arbitrarily selected subcellular fractions to whole tis-
sue values is difﬁcult or even impossible.
Materials and methods
Human liver
Samples of normal human liver tissue were obtained from two
donors undergoing surgical resections carried out at the Depart-
ment of Surgery at Uppsala University Hospital. The resections
were immediately snap-frozen in methyl butane on dry ice and
ethanol and were stored at150 C. All donors gave their informed
consent. Ethical approval was granted by the Uppsala Regional
Ethics Committee (ethical approvals 2009/028 and 2011/037).
Subcellular fractionation






:pieces on ice, and suspended in 3 ml of homogenization buffer
composedof 0.33Msucrose,10mMMgCl2, and50mMTriseHCl (pH
7.8). The tissue was homogenized at 0 C in a Teﬂoneglass Potter S
homogenizer at 1200 rpm with 30 downeup cycles. The homoge-
nate (H) was fractionated by successive centrifugation pelleting.
Fractions were collected after centrifugation at 1000 g for 10 min
(fractionA), 2000 g for 10min (fractionB), 5000 g for 10min (fraction
C),10,000 g for 10min (fraction D), and 21,000 g for 60min (fraction
E). The remaining supernatant was named cytosol (fraction F).Protein lysis and proteomic sample preparation
The fractions were lysed in 0.1 M TriseHCl (pH 8.0) containing
50 mM dithiothreitol (DTT) and 2% sodium dodecyl sulfate (SDS)
(w/v) in boiling water for 4 min. After cooling to room temperature,
the lysates were clariﬁed by centrifugation at 16,000 g for 10 min.
The lysates were processed according to the MEDeFASP (multiple
enzymes for sample digestioneﬁlter-aided sample preparation)
protocol using endoproteinase LysC and trypsin [13]. Total protein
and total peptide contents were determined using the trypto-
phaneﬂuorescence (WF) assay, as described recently [12].LCeMS/MS and data analysis
Aliquots containing 6-mg peptides were separated on a reversephase column (50 cm  75 mm i.d.) packed with 1.8 mm C18 using a
3-h acetonitrile gradient in 0.1% formic acid at a ﬂow rate of 200 nl/
min. The liquid chromatography (LC) was coupled to a Q Exactive
HF mass spectrometer (Thermo Fisher Scientiﬁc, Germany) via a
nanoelectrospray source (Proxeon Biosystems, now Thermo Fisher
Scientiﬁc). The mass spectrometer operated in data-dependent
mode with survey scans acquired at a resolution of 60,000 in a
range of 300e1650 m/z. Up to the top 15 most abundant isotope
patterns with chargeþ2 from the survey scanwere selected with
an isolation window of 1.4 m/z and fragmented by HCD (higher
energy collisional dissociation) with normalized collision energies
of 25. The maximum ion injection times for the survey scan and the
tandemmass spectrometry (MS/MS) scans were 20 and 60 ms, and
the ion target values were 3  106 and 1  105, respectively. The
dynamic exclusion was 30 s.Data analysis
The MS data were analyzed using MaxQuant software (version
1.5.3.14). Proteins were identiﬁed by searching MS and MS/MS data
of peptides against a decoy version of UniProtKB (August 2015)
containing 50,807 sequences. The search was performed with a
fragment ion mass tolerance of 0.5 Da and a parent ion tolerance of
20 ppm. The protein and peptide false discovery rates were set to
1%. Protein abundances were calculated from the spectral raw in-
tensities using the TPA [6,7] with the relationships:
Total proteinðiÞ ¼ MS signalðiÞ
Total MS signalProtein yields in the subcellular fractions were assessed using
the biochemically (bioch.) measured total protein concentration by
the WF assay, and the “virtual” protein concentrations were
calculated using the TPA:
Protein yieldðiÞ ¼ Protein concentration ðiÞ

P
bioch: total protein in fractions
bioch: total protein in homogenate

:
Calculations were performed in Excel (Microsoft). Statistical
analyses were carried out in SigmaPlot12 (SigmaPlot).Results
Fractionation of human liver and identiﬁcation of proteins
The human liver samples originated from two donors and were
processed separately. Pieces of tissue (100 mg) were homogenized
and fractionated by differential pelleting into ﬁve fractions, A to E,
where fraction A was expected to be dominated by nuclei and
fractions B, C, D, and E were expected to be dominated by mito-
chondria, membrane fractions from Golgi body, endoplasmic re-
ticulum (ER), and plasma membranes, respectively. The remaining
supernatant was named cytosol (fraction F) (Fig. 1A). Aliquots of the
homogenate and the entire fractions A to F were lysed in SDS-
Fig.1. Tissue fractionation and proteomic analysis workﬂows applied to human liver samples. Frozen human liver samples were homogenized in buffered 0.25 M sucrose and the
homogenate (A) was fractionated by differential pelleting into six fractions, A to F. Triplicate aliquots of each subcellular fraction were lysed in 2% SDS and processed by the
MEDeFASP procedure using endoproteinase LysC and trypsin. The released peptides were analyzed by LCeMS/MS, and the spectra were searched using MaxQuant software.
Concentrations of individual proteins were assessed by the TPA. (B) Balance of the total protein content in the homogenates and centrifugal fractions, A to F. (C) Protein identi-
ﬁcations and quantiﬁcation. In total, 8762 proteins were identiﬁed, of which 4586 were identiﬁed with at least ﬁve peptides and were found in each fraction.
Table 1
Distribution and recoveries of total protein.








H Homogenate 16.3 16.6 16.45 100.0
A 1000 g, 10 min 10.1 9.8 9.95 60.5
B 2000 g, 10 min 2.3 2.2 2.25 13.7
C 5000 g, 10 min 1.3 1.3 1.3 7.9
D 10,000 g, 10 min 0.66 0.48 0.57 3.5
E 21,000 g, 60 min 0.88 0.52 0.70 4.3
F Cytosol 3.2 3.1 3.15 19.1
Sum fractions AF (mg) 18.44 17.4 17.92
Yield (%)a 113 104 108
a Yield ¼ {S(fractions AF)/homogenate}*100%.
J.R. Wisniewski et al. / Analytical Biochemistry 509 (2016) 82e8884containing buffer. The sum of the total protein contents in the
generated fractions (fractions AeF in Fig. 1A) was close to 100% of
the total protein content in the homogenate, indicating high yield
of the preparative procedures (Fig. 1B and Table 1). Fraction A wasmost prominent, comprising approximately 50% of total protein of
the homogenate. In contrast, the pellet collected at 21,000 g (frac-
tion E) contained only 3e5% of the total protein (Table 1).
The MEDeFASP procedure allowed conversion of the proteins
Fig.2. Quantitative analysis of the data across the fractions. (A) Comparison of protein concentrations measured in 2 k, 5 k, 10 k, and 20 k fractions in two independent experiments
(1 and 2). P, Pearson correlation coefﬁcient. (B) Yields of 4586 quantiﬁed proteins. There is a statistically signiﬁcant difference between the median of the group and the hy-
pothesized population median at P < 0.001. The highlighted area indicates 95% of the yield values. (C) Yields and partition of the selected proteins in the subcellular fractions relative
to the homogenate. For 60 S ribosome, nuclear pore, ATP synthase and ADP/ATP transporter average values of their subunits are shown. The numbers of subunits are given in
parentheses.
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analyzed by LCeMS/MS in triplicates (Fig. 1A), and the analysis led
to the identiﬁcation of 111,000 peptides representing 8762 proteins
(Fig. 1C; see also Supplemental Table 1 in the online supplementary
material). Of these, 4586 proteins were identiﬁed by at least ﬁve
peptides and were found in each subcellular fraction and in the
homogenate. Only this subset of identiﬁed protein was subject to
further quantitative analyses by the TPA providing absolute values
(i.e., protein fractions per total protein or speciﬁc protein concen-
tration in mol per mass of total protein) (Supplemental Table 1).
These values allowed yield calculations of individual proteins
across the fractions compared with the homogenate.
Quantitative analysis of protein fractions
Comparison of the MS-based protein concentration data
showed a good correlation between both experiments (Fig. 2A).Combining the values of total protein per fraction (Table 1) with the
protein concentrations (Supplemental Table 1) enabled calculation
of balances between fractions A to F and the homogenate for the
quantiﬁed proteins. Fully 95% of these values were within the in-
terval of 50e200% (highlighted area in Fig. 2B). A one-sample t-test
revealed a statistically signiﬁcant difference between themedian of
the yield values and the hypothesized yields population median
(P < 0.001), indicating on average excellent recovery of the majority
of the proteins. Fig. 2C shows examples of the distribution of pro-
tein contents across fractions compared with the homogenate.
Proteins speciﬁc to plasmamembrane such as subunit A of (Naþ/
Kþ)ATPase (ATP1A1) and the glucose transporter Glut2 (SLC2A2)
were distributed across all fractions, with their largest portion
being in the “nuclear pellet” (fraction A) (Fig. 2C). Similar distri-
bution of the protein contents was also observed for membrane
proteins involved in drug transport and degradation processes
(ADME [absorption, distribution, metabolism, and excretion]
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constitutive nuclear location, such as histone H4, RNAepolymerase
II, and nuclear pore complex subunits, were present in at least 95%
of fraction A, whereas soluble cytoplasmic proteins were present
mainly in the cytosolic fraction (fraction F). The transcription factor
NFkB (nuclear factor kappa B) that is known to shuttle between the
cytoplasm and nucleus was identiﬁed at 60% in nucleus and 30% in
cytoplasm. Unexpectedly, considerable amounts of 20e30% of the
total content of non-membrane proteins of the mitochondrial
matrix, such as citrate synthase and malate dehydrogenase 2, were
found in the cytosol fraction. This presumably reﬂects leakage from
mitochondria due to tissue freezing.
Analysis of the quantitative distribution of the proteins across
the fractions revealed that the 21,000 g supernatant (fraction F)
contained negligible low amounts of membrane proteins from
plasma membrane, ER, and mitochondria (Fig. 2C). This indicates
that using medium-speed (21,000 g) centrifugation is sufﬁcient to
obtain complete microsomal fraction and that ultracentrifugation
at 100,000 g would not be required. Notably, a similar observation
was made by Abas and Luschnig for plant microsomes [14].
Subcellular distribution of membrane proteins involved in
xenobiotics elimination
The hepatobiliary elimination of drugs and other xenobiotics
consists of four major stages. It commences by basolateral uptake,
involves two phases of metabolism, and terminates by biliary
(canalicular) or apical efﬂux of the metabolites (Fig. 3A). Membrane
transport proteins of the solute carrier (SLC) family facilitate theFig.3. Group-speciﬁc enrichment proﬁles of the key proteins involved in drug transport and
by hepatocytes. (BeF) Partition of the (Naþ/Kþ)ATPase (B) and proteins involved in basolater
respectively). Protein enrichment values were calculated against concentrations in the 2 khepatic uptake of drugs, whereas excretion into the bile and blood
is mainly carried out by transporters of the ATP-binding cassette
(ABC) family. Cytochrome P450s (CYPs) and UDPeglucuronosyl-
transferases (UGTs) are key enzymes of the phase I and phase II
metabolism of xenobiotics. To analyze the distribution of these
proteins across the subcellular fractions, we calculated the
enrichment in fractions E and F, respectively, relative to the “post-
nuclear” fraction C. We observed that each group of the proteins
important for the xenobiotic clearance clustered together in
different fractions, revealing speciﬁc enrichment proﬁles
(Fig. 3BeE). The transporters showed a continuous enrichment
with the increased centrifugal speed used for fraction collection
(Fig. 3B and C). In contrast, the enzymes did not follow this trend
(Fig. 3D and E). Notably, proteins located in the basolateral and
canalicular plasma membranes, respectively, were not distributed
equally (Fig. 3B and C). (Naþ/Kþ)ATPase that is abundant in the
basolateral membrane had an enrichment proﬁle similar to that of
the basolaterally located transporters, supporting the notion that
this protein can be used as a marker for sinusoidal plasma mem-
brane fractions [4] (cf. Fig. 3F and B). The efﬂux transporter ABCC3,
which is also located in the basolateral plasma membrane, showed
an enrichment proﬁle similar to that of the basolateral uptake
transporters. Because the basolateral transporters were also found
in the other fractions, we compared the protein concentrations of
the transporters with the (Naþ/Kþ)ATPase across all fractions and
the homogenate (Fig. 4). All transporters of the basolateral mem-
brane showed a good correlation with the ATPase. In contrast, the
canalicular transporters ABCC2 and ABCG5 did not correlate with
the ATPase titers.metabolism. (A) Scheme of the hepatobiliary elimination of drugs and other xenobiotics
al uptake (C), biliary/sinusoidal efﬂux (D), and phase I and phase II metabolism (E and F,
fraction.
Fig.4. Correlation of the membrane transporter and (Naþ/Kþ)ATPase concentrations
across the fractions (AeE) and homogenate. (AeC) Correlation of protein concentra-
tions of ATP1B1 (subunit B of (Naþ/Kþ)ATPase), SLC22A7, and ABCG5 with ATP1A1
(subunit A of (Naþ/Kþ)ATPase). Each data point reﬂects a single measurement. (D)
Heatmap with P-values of the Spearman rank correlations between the transporters of
the sinusoidal (black), canalicular (blue), and plasma membrane (Naþ/Kþ)ATPase
(green). Correlation plots shown in panels A, B, and C are a part of the heatmap.
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Subcellular fractionation of animal liver tissue has been the
subject of many studies. In contrast, reports on fractionation of
human liver tissue are scarce [15,16]. This presumably reﬂects
limited availability of fresh human tissue for research as well as
difﬁculties in subcellular fractionation of cryopreserved tissue. A
study on subcellular fractionation comparing fresh and frozen
murine liver tissues revealed signiﬁcantly decreased yields after
fractionation of the frozen tissue [17]. This was in agreement with
extensive damage of mitochondria and nuclei in the subcellular
fractions from the frozen material, as observed by electron micro-
scopy. Both factors negatively inﬂuenced the separation of
organelles.
Our analyses are in line with these ﬁndings. We observed that,
with the exception of nuclei, all organelle-speciﬁc proteins were
widely distributed among the different pellet fractions. Based on
the total protein measurements, more than 50% of the subcellular
material was recovered in the ﬁrst fraction collected at 1000 g
(fraction A). This fraction is often considered as nuclear, but in
hepatocytes, the major cell fraction in liver, nuclei account for 5e7%
of the cell volume [18] and approximately 10% of the total cellprotein [10]. Thus, our results indicate that approximately 90% of
this fraction contains cell material that is inert to standard ho-
mogenization. Inversely, fraction E comprised only 3e5% of the
total protein, which is 2e3 times less than what had been isolated
from fresh human liver tissue [19]. In addition, we also found a
portion of mitochondria-speciﬁc soluble enzymes in the cytosolic
fraction. This seems to be an indication of freezing-associated
damage of mitochondria and subsequent leakage of soluble com-
ponents from the matrix. Apart from the effect of the structural
damage on the fractionation procedure, two other factors may
contribute to suboptimal distribution of the mitochondrial pro-
teins: the occurrence of large amounts of glycogen and blood in
liver tissue.
Human liver accumulates large amounts of glycogen, which can
constitute up to 10% (w/w) of the tissue. The effects of this natural
polymer on subcellular fractionation have already been recognized
in the past, and therefore animals are routinely starved before ex-
periments [20]. Because human liver samples may contain signiﬁ-
cant amounts of glycogen, a possible effect of this polymer on
subcellular fractionation cannot be ruled out. However, the
glycogen levels were most likely lowered in our samples due to
standard fasting regimes prior to surgery. The second factor, the
occurrence of blood, that potentially affects the subcellular frac-
tionation can, at least, be partially eliminated by washing of fresh
liver cut into small fragments. Coagulation of blood can also be a
problem, which is prevented by adding ethylenediaminetetraacetic
acid (EDTA) to the homogenization buffer. In the frozen tissue,
blood is coagulated and the clots may generate aggregates during
the tissue homogenization. In line with this, we found one of the
most abundant blood proteins, hemoglobin, in all subcellular
fractions at concentrations similar to or exceeding that in the ho-
mogenate (see Supplemental Table 1 in supplementary material).
Furthermore, data generated from targeted spike-in analyses
are often considered as accurate. However, the results can be
heavily biased by partial digestion [21] of the samples and the fact
that single or only few peptides are used for the quantiﬁcation. This
seems to be one of the reasons for large differences in concentra-
tions of the ADME proteins in liver, reported by several groups
[22,23]. In contrast, in global proteomic analysis using the TPA,
protein abundances are calculated on the basis of spectral MS1 in-
tensities of many peptides. For example, in this study the concen-
trations of the 4586 proteins were calculated on the basis of, on
average, 20 peptides per protein against 111,000 peptides in the
whole dataset. In this context, we also should refer to our recent
study showing a comparison of the TPA and a spike in the prEST
(protein epitope signature tag) approach [24] that revealed an
average deviation of only 1.5-fold in the protein titers calculated by
both methods [6].
Traditionally, subcellular fractionation of tissue was accompa-
nied by determination of total protein content and enzymatic ac-
tivities across all fractions and the homogenate. This information
allowed calculation of yields of the procedure and gave indications
of the content and purity of the isolated subcellular fractions. Over
time, many of the laborious biochemical assays were replaced by
Western blot analyses. At best, both biochemical and Western blot
analyses enable insights into the subcellular distribution of a
limited number of proteins. In contrast, large-scale proteomics can
provide a system-wide picture based on quantitative analysis of all
fractions obtained. The TPA allows quantitative analyses of thou-
sands of proteins, assessing their content and concentrations across
all analyzed fractions. Combining the TPA data with biochemical
total protein measurements enables calculation of the protein
contents per individual fraction. This information provides quan-
titative insights into the subcellular distribution of proteins and can
be used as a guide for development of fractionation procedures.
J.R. Wisniewski et al. / Analytical Biochemistry 509 (2016) 82e8888Our analyses clearly demonstrate that upscaling of the quanti-
tative data generated for single subcellular fractions is not possible
without knowledge of the actual subcellular location and enrich-
ment factors. Furthermore, our analysis indicates that membrane
proteins involved in different phases of xenobiotics elimination are
heterogeneously distributed in the liver cells, and therefore their
abundance in liver cannot be correctly assessed from analysis of
single fractions such as the microsomal fraction.
Conclusions
We demonstrate that subcellular fractionation of frozen human
tissue is a difﬁcult task that does not result in fractions identical to
those that can be achieved from fresh animal tissue. We combined
total protein assays with values of virtually quantiﬁed proteins
using the TPA in order to calculate a quantitative yield balance
between the summed subcellular fractions and the homogenate.
Our data show that measuring protein levels in single subcellular
fractions does not allow simple upscaling of data to whole tissue. In
contrast, this can be achieved by label-free in-depth proteomics
analysis of whole tissue lysate and the computational tool, the TPA.
To our knowledge, this study also provides the ﬁrst absolute
quantitative subcellular catalog of human liver proteins obtained
from frozen tissue specimens.
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